Krishna Institute of Medical Sciences Limited Share Price Bombay S.E.

Equities

KIMS

INE967H01017

Healthcare Facilities & Services

Market Closed - Bombay S.E. 11:00:52 28/06/2024 BST 5-day change 1st Jan Change
2,084 INR -0.92% Intraday chart for Krishna Institute of Medical Sciences Limited +1.42% +5.35%

Financials

Sales 2024 24.98B 300M 23.71B Sales 2025 * 29.53B 354M 28.02B Capitalization 167B 2B 158B
Net income 2024 3.1B 37.21M 2.94B Net income 2025 * 3.73B 44.72M 3.54B EV / Sales 2024 6.96 x
Net Debt 2024 9.14B 110M 8.68B Net Debt 2025 * 10.94B 131M 10.39B EV / Sales 2025 * 6.02 x
P/E ratio 2024
53.1 x
P/E ratio 2025 *
44.8 x
Employees 4,588
Yield 2024 *
0.28%
Yield 2025 *
0.17%
Free-Float 53.71%
More Fundamentals * Assessed data
Dynamic Chart
16,040,662 Equity Shares of Krishna Institute of Medical Sciences Limited are subject to a Lock-Up Agreement Ending on 22-JUN-2024. CI
Krishna Institute of Medical Sciences Signs Deal to Set Up New Hospital in Bengaluru, India MT
Krishna Institute of Medical Sciences to Invest Up to INR713 Million in Wholly Owned Arm MT
Krishna Institute of Medical Sciences Logs Lower Consolidated Net Profit in Fiscal Q4 MT
Transcript : Krishna Institute of Medical Sciences Limited, Q4 2024 Earnings Call, May 17, 2024
Krishna Institute of Medical Sciences Buys Land For New Hospital in Thane, India MT
Krishna Institute of Medical Sciences Plans INR5 Billion Investment to Build Hospital in Thane, India MT
Krishna Institute of Medical Sciences Limited Enters into Definitive Agreements for Taking Land on A 99-Year Lease and Purchase of Building for the Setting Up of New Hospital At Thane CI
Krishna Institute of Medical Sciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Krishna Institute of Medical Sciences Limited Announces Cessation of Rajeswara Rao Gandu as Independent Director CI
Krishna Institute of Medical Sciences Limited acquired 5.04% stake in KIMS-SUNSHINE Hospitals for INR 740 million. CI
Krishna Institute of Medical Sciences Limited Announces Ceasation of Pankaj Vaish as Independent Director CI
BCAL Diagnostics Joins Forces to Conduct Breast Cancer Blood Test Study in India MT
Krishna Institute of Medical Sciences Limited Appoints Adwik Bollineni as Additional Director CI
Krishna Institute Of Medical Sciences Reports Decline in Fiscal Q2 Consolidated Net Profit MT
More news

Latest transcript on Krishna Institute of Medical Sciences Limited

1 day-0.92%
1 week+1.42%
Current month+14.06%
1 month+12.69%
3 months+1.25%
6 months+4.22%
Current year+5.35%
More quotes
1 week
2 030.85
Extreme 2030.85
2 187.45
1 month
1 750.10
Extreme 1750.1
2 187.45
Current year
1 750.10
Extreme 1750.1
2 357.00
1 year
1 625.05
Extreme 1625.05
2 357.00
3 years
938.05
Extreme 938.05
2 357.00
5 years
938.05
Extreme 938.05
2 357.00
10 years
938.05
Extreme 938.05
2 357.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 36 31/12/14
Director of Finance/CFO - 31/07/23
Chairman 70 11/11/02
Members of the board TitleAgeSince
Director/Board Member 62 07/01/21
Director/Board Member 70 18/05/22
Chairman 70 11/11/02
More insiders
Date Price Change Volume
28/06/24 2,084 -0.92% 12,562
27/06/24 2,103 -1.06% 2,830
26/06/24 2,126 -0.14% 8,023
25/06/24 2,128 +3.60% 7,688
24/06/24 2,054 -0.01% 9,297

Delayed Quote Bombay S.E., June 28, 2024 at 11:00 am

More quotes
Krishna Institute of Medical Sciences Ltd is an India-based company, which is principally engaged in the business of rendering medical and healthcare services. The Company’s departments include accident, Alzheimer center, andrology and infertility center, pediatric obesity, pediatric oncology, pediatric oncology and hematology center, pediatric orthopedics and rheumatology, pediatric renal center, pediatric surgical center, female urology center, fertility center, gastrointestinal oncology, general surgery, heart wellness center, hepatobiliary surgery center, and others. Its medical technologies include 4-Arm HD da Vinci Robotic Surgical System, O-Arm Scanner, Novalis Tx Linear Accelerator, 3 Tesla MRI, EBUS, Spy Glass, Mako Robotic for Knee Replacement, Impella, and others. The Company’s institutes include Institute of Cardiac Sciences, Institute of Dental Science, Institute of Gastroenterology & Hepatology, Institute of Heart & Lung Transplantation, among others.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
2,084 INR
Average target price
2,257 INR
Spread / Average Target
+8.29%
Consensus